Intravenous (IV) Iron Drugs Market Will Benefit from Approval of I.V. TRIFERIC® By FDA, says Fortune Business Insights

(The Express Wire via Comtex)

Rising demand for preventive care is a key factor driving the global “intravenous (IV) iron drugs market”, says Fortune Business Insights in a report, titled “Intravenous (IV) Iron Drugs Market Size, Share and Global Trend By Type (Iron Sucrose, Dextran, Ferric Carboxyl Maltose, Ferric Gluconate), By Application (Gynecology, Oncology, Nephrology), By End User (Hospitals, Ambulatory Surgery Centers, Homecare Settings) and Geography Forecast till 2026.” Increasing RandD investments in intravenous iron by key players is expected to aid the growth of the global intravenous (IV) iron drugs market. According to the report, the rising prevalence of anemia is predicted to contribute positively to the global intravenous (IV) iron drugs market revenue.

The report includes thorough compilation of the quantitative analysis of the industry for the period of 12 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period. This study includes a widespread analysis of the key segments of the industry. This analysis sheds light in the current trends and opportunities in the Intravenous (IV) Iron Drugs Market.

Request a Sample Copy of the Research Report:

Key Points of the Intravenous (IV) Iron Drugs Market Report:

  • The report provides a basic overview of the industry including its definition, applications, and manufacturing technology.
  • The report also explores the major international players in detail. In this part, the report presents the company profile, product specifications, capacity, and production value along with the market shares for each company.
  • Through the statistical analysis, the study depicts the global market including capacity, production, production value, cost/profit, and supply/demand from an international perspective.
  • Considering segmentation, the market is divided in terms of product, end-use, company, region, and other important aspects. Each of these categories forms an important base point for the competitive landscape analysis.
  • The report then estimates the market development and trends of the Intravenous (IV) Iron Drugs Market.

Announcement of Feraheme® (ferumoxytol injection) by AMAG Pharmaceuticals

AMAG Pharmaceuticals, Inc., an American pharmaceutical company dedicated to treating iron deficiency anemia in adult patients, announced the launch of Feraheme® (ferumoxytol injection), an existing label after receiving the approval from the Food and Drug Administration. The new drug will be used beyond the current chronic kidney disease (CKD) indication and henceforth, will also be by all eligible adult patients with Iron Deficiency Anemia (IDA) who have intolerance to oral iron or have had unsatisfactory response to oral iron.

Top manufactures of Intravenous (IV) Iron Drugs Market are:

  • Daiichi Sankyo, Inc.
  • Sanofi
  • AMAG Pharmaceuticals, Inc
  • Allergan
  • Nippon Shinyaku Co., Lt
  • Pharmacosmos A/S.
  • And others.

Increasing Awareness About Anemia Will Boost Growth in Asia Pacific

North America dominated the intravenous (IV) iron drugs market in 2018 due to the increasing prevalence of anemia and rising cases of associated diseases such as celiac disease along with inflammatory bowel disease. Moreover, high healthcare expenditure, access to advanced intravenous (IV) iron drugs and rising demand for preventive medical care will further favor growth in North America.

Have Any Query? Ask Our Experts:

Asia Pacific is predicted grow at a remarkable rate during the forecast period owing to the increasing awareness and cases of anemia and growing access to intravenous (IV) iron drugs. The rising prevalence of acute and severe diseases such as inflammatory bowel disease will also accelerate growth in North America. Latin America and the Middle East and Africa are expected to grow at a relatively lower CAGR during the forecast period.

Intravenous (IV) Iron Drugs Market Segmentation:

By Type

  • Iron Sucrose
  • Dextran
  • Ferric Carboxyl Maltose
  • Ferric Gluconate
  • Others

By Application

  • Gynecology
  • Oncology
  • Nephrology
  • Others

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Homecare Settings
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East and Africa (South Africa, GCC and Rest of Middle East and Africa)

Order Full Report:

Reasons to Purchase this Report:

  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Comprehensive analysis of the Aesthetic Implants Market growth drivers, obstacles, opportunities, and other related challenges.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Fortune Business Insights™


Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Intravenous (IV) Iron Drugs Market Will Benefit from Approval of I.V. TRIFERIC(R) By FDA, says Fortune Business Insights

comtex tracking